Literature DB >> 31377314

Circ-IGF1R has pro-proliferative and anti-apoptotic effects in HCC by activating the PI3K/AKT pathway.

Hang-Wei Fu1, Xia Lin2, Yuan-Xin Zhu1, Xiang Lan1, Yi Kuang1, Yu-Zhou Wang1, Zhi-Gang Ke3, Tao Yuan4, Ping Chen5.   

Abstract

Circular RNAs (circRNAs), a novel class of widespread and diverse endogenous RNAs, have been identified as critical regulators of various cancers, including hepatocellular carcinoma (HCC). However, the specific roles of circRNAs in HCC are largely unknown. In this study, we identified a novel circRNA, circ-IGF1R, in HCC tumour tissues and cell lines. Circ-IGF1R levels were found to be significantly upregulated in HCC tissues compared with levels in paired peritumoural tissues. The high expression levels of circ-IGF1R in HCC were associated with tumour size. Moreover, knocking down circ-IGF1R with siRNA significantly attenuated cell proliferation and induced cell apoptosis and cell cycle arrest in vitro. Further investigation revealed that PI3K/AKT signalling pathway activation was involved in the oncogenic functions of circ-IGF1R in HCC. Our study suggests that circ-IGF1R may be a potential target for the prevention and treatment of HCC.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cell proliferation; Circ-IGF1R; Hepatocellular carcinoma

Mesh:

Substances:

Year:  2019        PMID: 31377314     DOI: 10.1016/j.gene.2019.144031

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  22 in total

Review 1.  Circular RNAs in hepatocellular carcinoma: Recent advances.

Authors:  Zhao-Shan Niu; Wen-Hong Wang
Journal:  World J Gastrointest Oncol       Date:  2022-06-15

2.  Dexmedetomidine alleviates postoperative cognitive dysfunction through circular RNA in aged rats.

Authors:  Cao Cao; Fumou Deng; Yanhui Hu
Journal:  3 Biotech       Date:  2020-03-24       Impact factor: 2.406

Review 3.  Biological roles and potential clinical values of circular RNAs in gastrointestinal malignancies.

Authors:  Xueping Tao; Yongfu Shao; Jianing Yan; Liyang Yang; Qihua Ye; Qingling Wang; Rongdan Lu; Junming Guo
Journal:  Cancer Biol Med       Date:  2021-03-12       Impact factor: 4.248

Review 4.  Circular RNAs in Hepatocellular Carcinoma: Emerging Functions to Clinical Significances.

Authors:  Yucheng Zhang; Yali Wang
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

5.  ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.

Authors:  Han Chen; Hengxiao Wang; Xiqiao Yu; Shuping Zhou; Yueying Zhang; Zhaopeng Wang; Shuhong Huang; Zhaoxia Wang
Journal:  BMC Cancer       Date:  2020-09-05       Impact factor: 4.430

6.  Circ-IGF1R inhibits cell invasion and migration in non-small cell lung cancer.

Authors:  Zhanyu Xu; Weiwei Xiang; Wenjie Chen; Yu Sun; Fanglu Qin; Jiangbo Wei; Liqiang Yuan; Liping Zheng; Shikang Li
Journal:  Thorac Cancer       Date:  2020-02-27       Impact factor: 3.500

7.  MicroRNA‑153‑3p suppresses retinoblastoma cell growth and invasion via targeting the IGF1R/Raf/MEK and IGF1R/PI3K/AKT signaling pathways.

Authors:  Long Guo; Yu Bai; Tianyu Ni; Yuan Li; Rong Cao; Shuzhe Ji; Shuzhen Li
Journal:  Int J Oncol       Date:  2021-05-26       Impact factor: 5.650

8.  LLGL2 Increases Ca2+ Influx and Exerts Oncogenic Activities via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma.

Authors:  Shusheng Leng; Fei Xie; Junyi Liu; Junyi Shen; Guangqian Quan; Tianfu Wen
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

9.  Circular RNA SMARCA5 correlates with favorable clinical tumor features and prognosis, and increases chemotherapy sensitivity in intrahepatic cholangiocarcinoma.

Authors:  Qi Lu; Tao Fang
Journal:  J Clin Lab Anal       Date:  2019-12-27       Impact factor: 2.352

Review 10.  Circular RNA is a popular molecule in tumors of the digestive system (Review).

Authors:  Hao-Ying Wang; Yu-Ping Wang; Xi Zeng; Ya Zheng; Qing-Hong Guo; Rui Ji; Yong-Ning Zhou
Journal:  Int J Oncol       Date:  2020-04-27       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.